Mode of Action Analysis and Human Relevance of Liver Tumors Induced by PPAR α Activation

Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification

Volumn , Issue , 2010, Pages 439-481

  Corton, J Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Central role PPAR plays in mediating pleiotropic effects of exposure; Mode of action analysis and human relevance of liver tumors induced by PPAR activation; PPAR expression, cited for determining species specific differences in PPAR activator responsiveness

Indexed keywords

EID: 84872379546     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470622728.ch17     Document Type: Chapter

References (256)

1. Abdellatif, A. G., Preat, V., Vamecq, J., Nilsson, R., and Roberfroid, M. (1990). Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4 - dichlorophenoxyacetic acid, 2,4,5 - trichlorophenoxy-acetic acid, perfl uorooctanoic acid and nafenopin . Carcinogenesis 11, 1899-1902.
2. Anderson, S. P., Dunn, C., Laughter, A., Yoon, L., Swanson, C., Stulnig, T. M., Steffensen, K. R., Chandraratna, R. A., Gustafsson, J.A., and Corton, J. C. (2004a). Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver . Mol Pharmacol 66, 1440-1452.
3. Anderson, S. P., Dunn, C. S., Cattley, R. C., and Corton, J. C. (2001). Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling . Carcinogenesis 22, 1843-1851.
4. Anderson , S. P. , Howroyd , P. , Liu , J. , Qian , X. , Bahnemann , R. , Swanson , C. , Kwak , M. K. , Kensler , T. W. , and Corton , J. C. ( 2004b ). The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes . J Biol Chem 279 , 52390-52398 .
5. Arsura , M. , and Cavin , L. G. ( 2005 ). Nuclear factor-kappaB and liver carcinogenesis . Cancer Lett 229 , 157-169 .
6. Ashby , J. , Brady , A. , Elcombe , C. R. , Elliott , B. M. , Ishmael , J. , Odum , J. , Tugwood , J. D. , Kettle , S. , and Purchase , I. F. ( 1994 ). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis . Hum Exp Toxicol 13 ( Suppl 2 ), S1-S117 .
7. Auwerx , J. , Schoonjans , K. , Fruchart , J. C. , and Staels , B. ( 1996 ). Transcriptional control of triglyceride metabolism: fi brates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR . Atherosclerosis 124 ( Suppl), S29-S37 .
8. Barrass , N. C. , Price , R. J. , Lake , B. G. , and Orton , T. C. ( 1993 ). Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofi bric acid in rat liver . Carcinogenesis 14 , 1451-1456 .
9. Bayly , A. C. , Roberts , R. A. , and Dive , C. ( 1994 ). Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin . J Cell Biol 125 , 197-203 .
10. Becuwe , P. , and Dauca , M. ( 2005 ). Comparison of cytotoxicity induced by hypolipidemic drugs via reactive oxygen species in human and rodent liver cells . Int J Mol Med 16 , 483-492 .
11. Bell , A. R. , Savory , R. , Horley , N. J. , Choudhury , A. I. , Dickins , M. , Gray , T. J. , Salter , A. M. , and Bell , D. R. ( 1998 ). Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia . Biochem J 332 ( Pt 3 ), 689-693 .
12. Bell , D. R. , Plant , N. J. , Rider , C. G. , Na , L. , Brown , S. , Ateitalla , I. , Acharya , S. K. , Davies , M. H. , Elias , E. , Jenkins , N. A. , and et al. ( 1993 ). Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs . Biochem J 294 ( Pt 1 ), 173-180 .
13. Bentley , P. , Calder , I. , Elcombe , C. , Grasso , P. , Stringer , D. , and Wiegand , H. J. ( 1993 ). Hepatic peroxisome proliferation in rodents and its significance for humans . Food Chem Toxicol 31 , 857-907 .
14. Bichet , N. , Cahard , D. , Fabre , G. , Remandet , B. , Gouy , D. , and Cano , J. P. ( 1990 ). Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture . Toxicol Appl Pharmacol 106 , 509-517 .
15. Bility , M. T. , Thompson , J. T. , McKee , R. H. , David , R. M. , Butala , J. H. , Vanden Heuvel , J. P. , and Peters , J. M. ( 2004 ). Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters . Toxicol Sci 82 , 170-182 .
16. Blumcke , S. , Schwartzkopff , W. , Lobeck , H. , Edmondson , N. A. , Prentice , D. E. , and Blane , G. F. ( 1983 ). Infl uence of fenofi brate on cellular and subcellular liver structure in hyperlipidemic patients . Atherosclerosis 46 , 105-116 .
17. Bojes , H. K. , Germolec , D. R. , Simeonova , P. , Bruccoleri , A. , Schoonhoven , R. , Luster , M. I. , and Thurman , R. G. ( 1997 ). Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643 . Carcinogenesis 18 , 669-674 .
18. Boobis , A. R. , Cohen , S. M. , Dellarco , V. , McGregor , D. , Meek , M. E. , Vickers , C. , Willcocks , D. , and Farland , W. ( 2006 ). IPCS framework for analyzing the relevance of a cancer mode of action for humans . Crit Rev Toxicol 36 , 781-792 .
19. Boobis , A. R. , Doe , J. E. , Heinrich-Hirsch , B. , Meek , M. E. , Munn , S. , Ruchirawat , M. , Schlatter , J. , Seed , J. , and Vickers , C. ( 2008 ). IPCS framework for analyzing the relevance of a noncancer mode of action for humans . Crit Rev Toxicol 38 , 87-96 .
20. Burkhardt , S. , Mellert , W. , Reinachet , M. , and Bahnemann , R. ( 2001 ). Zonal evaluation of proliferation and apoptosis in the liver of mice reveals new mechanistic data for phenobarbital (PB), Wyeth 14,643 (WY), and chloroform (CH) . The Toxicologist 60 , 286 (Abstract #1362).
21. Burns , K. A. , and Vanden Heuvel , J. P. ( 2007 ). Modulation of PPAR activity via phosphorylation . Biochim Biophys Acta 1771 , 952-960 .
22. Bursch , W. , Lauer , B. , Timmermann-Trosiener , I. , Barthel , G. , Schuppler , J. , and Schulte-Hermann , R. ( 1984 ). Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters . Carcinogenesis 5 , 453-458 .
23. Busser , M. T. , and Lutz , W. K. ( 1987 ). Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters . Carcinogenesis 8 , 1433-1437 .
24. Cai , Y. , Appelkvist , E. L. , and DePierre , J. W. ( 1995 ). Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators . J Biochem Toxicol 10 , 87-94 .
25. Caira , F. , Clemencet , M. C. , Cherkaoui-Malki , M. , Dieuaide-Noubhani , M. , Pacot , C. , Van Veldhoven , P. P. , and Latruffe , N. ( 1998 ). Differential regulation by a peroxisome proliferator of the different multifunctional proteins in guinea pig: cDNA cloning of the guinea pig D-specific multifunctional protein 2 . Biochem J 330 ( Pt 3 ), 1361-1368 .
26. Calfee-Mason , K. G. , Spear , B. T. , and Glauert , H. P. ( 2004 ). Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofi brate . Toxicol Appl Pharmacol 199 , 1-9 .
27. Cariello , N. F. , Romach , E. H. , Colton , H. M. , Ni , H. , Yoon , L. , Falls , J. G. , Casey , W. , Creech , D. , Anderson , S. P. , Benavides , G. R. , Hoivik , D. J. , Brown , R. , and Miller , R. T. ( 2005 ). Gene expression profi ling of the PPAR-alpha agonist ciprofi brate in the cynomolgus monkey liver . Toxicol Sci 88 , 250-264 .
28. Cattley , R. C. , Conway , J. G. , and Popp , J. A. ( 1987 ). Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years . Cancer Lett 38 , 15-22 .
29. Cattley , R. C. , DeLuca , J. , Elcombe , C. , Fenner-Crisp , P. , Lake , B. G. , Marsman , D. S. , Pastoor , T. A. , Popp , J. A. , Robinson , D. E. , Schwetz , B. , Tugwood , J. , and Wahli , W. ( 1998 ). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27 , 47-60 .
30. Cattley , R. C. , and Glover , S. E. ( 1993 ). Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization . Carcinogenesis 14 , 2495-2499 .
31. Chan , E. , Tan , C. S. , Deurenberg-Yap , M. , Chia , K. S. , Chew , S. K. , and Tai , E. S. ( 2006 ). The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women . Atherosclerosis 187 , 309-315 .
32. Chang , C. K. , Llanes , S. , and Schumer , W. ( 1997 ). Effect of dexamethasone on NF-kB activation, tumor necrosis factor formation, and glucose dyshomeostasis in septic rats . J Surg Res 72 , 141-145 .
33. Chen , H. , Huang , C. Y. , Wilson , M. W. , Lay , L. T. , Robertson , L. W. , Chow , C. K. , and Glauert , H. P. ( 1994 ). Effect of the peroxisome proliferators ciprofi brate and perfl uorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats . Carcinogenesis 15 , 2847-2850 .
34. Cheung , C. , Akiyama , T. E. , Ward , J. M. , Nicol , C. J. , Feigenbaum , L. , Vinson , C. , and Gonzalez , F. J. ( 2004 ). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha . Cancer Res 64 , 3849-3854 .
35. Chinje , E. , Kentish , P. , Jarnot , B. , George , M. , and Gibson , G. ( 1994 ). Induction of the CYP4A subfamily by perfl uorodecanoic acid: the rat and the guinea pig as susceptible and non-susceptible species . Toxicol Lett 71 , 69-75 .
36. Choudhury , A. I. , Chahal , S. , Bell , A. R. , Tomlinson , S. R. , Roberts , R. A. , Salter , A. M. , and Bell , D. R. ( 2000 ). Species differences in peroxisome proliferation; mechanisms and relevance . Mutat Res 448 , 201-212 .
37. Choudhury , A. I. , Sims , H. M. , Horley , N. J. , Roberts , R. A. , Tomlinson , S. R. , Salter , A. M. , Bruce , M. , Shaw , P. N. , Kendall , D. , Barrett , D. A. , and Bell , D. R. ( 2004 ). Molecular analysis of peroxisome proliferation in the hamster . Toxicol Appl Pharmacol 197 , 9-18 .
38. Conway , J. G. , Tomaszewski , K. E. , Olson , M. J. , Cattley , R. C. , Marsman , D. S. , and Popp , J. A. ( 1989 ). Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643 . Carcinogenesis 10 , 513-519 .
39. Cornu-Chagnon , M. C. , Dupont , H. , and Edgar , A. ( 1995 ). Fenofi brate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes . Fundam Appl Toxicol 26 , 63-74 .
40. Corton , J. C. ( 2008 ). Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites . Crit Rev Toxicol 38 , 857-875 .
41. Corton , J. C. , Anderson , S. P. , and Stauber , A. ( 2000 ). Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators . Annu Rev Pharmacol Toxicol 40 , 491-518 .
42. Corton , J. C. , Apte , U. , Anderson , S. P. , Limaye , P. , Yoon , L. , Latendresse , J. , Dunn , C. , Everitt , J. I. , Voss , K. A. , Swanson , C. , Kimbrough , C. , Wong , J. S. , Gill , S. S. , Chandraratna , R. A. , Kwak , M. K. , Kensler , T. W. , Stulnig , T. M. , Steffensen , K. R. , Gustafsson , J. A. , and Mehendale , H. M. ( 2004 ). Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors . J Biol Chem 279 , 46204-46212 .
43. Corton , J. C. , and Lapinskas , P. J. ( 2005 ). Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract? Toxicol Sci 83 , 4-17 .
44. Currie , R. A. , Bombail , V. , Oliver , J. D. , Moore , D. J. , Lim , F. L. , Gwilliam , V. , Kimber , I. , Chipman , K. , Moggs , J. G. , and Orphanides , G. ( 2005 ). Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: Application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate . Toxicol Sci 86 , 453-469 .
45. Czaja , M. J. ( 2007 ). Cell signaling in oxidative stress-induced liver injury . Semin Liver Dis 27 , 378-389 .
46. De Bosscher , K. , Vanden Berghe , W. , and Haegeman , G. ( 2006 ). Cross-talk between nuclear receptors and nuclear factor kappaB . Oncogene 25 , 6868-6886 .
47. de Duve , C. ( 1996 ). The peroxisome in retrospect . Ann N Y Acad Sci 804 , 1-10 .
48. De La Iglesia , F. A. , Lewis , J. E. , Buchanan , R. A. , Marcus , E. L. , and McMahon , G. ( 1982 ). Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfi brozil treatment . Atherosclerosis 43 , 19-37 .
49. De Minicis , S. , Bataller , R. , and Brenner , D. A. ( 2006 ). NADPH oxidase in the liver: defensive, offensive, or fi brogenic? Gastroenterology 131 , 272-275 .
50. Desvergne , B. , A , I. J. , Devchand , P. R. , and Wahli , W. ( 1998 ). The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling . J Steroid Biochem Mol Biol 65 , 65-74 .
51. Desvergne , B. , and Wahli , W. ( 1999 ). Peroxisome proliferator-activated receptors: nuclear control of metabolism . Endocr Rev 20 , 649-688 .
52. Dostalek , M. , Hardy , K. D. , Milne , G. L. , Morrow , J. D. , Chen , C. , Gonzalez , F. J. , Gu , J. , Ding , X. , Johnson , D. A. , Johnson , J. A. , Martin , M. V. , and Guengerich , F. P. ( 2008 ). Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems . J Biol Chem 283 , 17147-17157 .
53. Doull , J. , Cattley , R. , Elcombe , C. , Lake , B. G. , Swenberg , J. , Wilkinson , C. , Williams , G. , and van Gemert , M. ( 1999 ). A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA Risk Assessment Guidelines . Regul Toxicol Pharmacol 29 , 327-357 .
54. Dreyer , C. , Krey , G. , Keller , H. , Givel , F. , Helftenbein , G. , and Wahli , W. ( 1992 ). Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors . Cell 68 , 879-887 .
55. Duclos , S. , Bride , J. , Ramirez , L. C. , and Bournot , P. ( 1997 ). Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofi brate . Eur J Cell Biol 72 , 314-323 .
56. Dwivedi , R. S. , Alvares , K. , Nemali , M. R. , Subbarao , V. , Reddy , M. K. , Usman , M. I. , Rademaker , A. W. , Reddy , J. K. , and Rao , M. S. ( 1989 ). Comparison of the peroxisome proliferator-induced pleiotropic response in the liver of nine strains of mice . Toxicol Pathol 17 , 16-26 .
57. Elcock , F. J. , Chipman , J. K. , and Roberts , R. A. ( 1998 ). The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis . Arch Toxicol 72 , 439-444 .
58. Elcombe , C. R. ( 1985 ). Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment . Arch Toxicol Suppl 8 , 6-17 .
59. Elcombe , C. R. , Bell , D. R. , Elias , E. , Hasmall , S. C. , and Plant , N. J. ( 1996 ). Peroxisome proliferators: species differences in response of primary hepatocyte cultures . Ann N Y Acad Sci 804 , 628-635 .
60. Elliott , B. M. , and Elcombe , C. R. ( 1987 ). Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators . Carcinogenesis 8 , 1213-1218 .
61. EPA ( 2005a ). Guidelines for carcinogen risk assessment . EPA/630/P-03/001F , 1-166 , http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=439797 .
62. EPA ( 2005b ). Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens . EPA/630/R-03/003F , 1-126 , http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=459042 .
63. Fan , C. Y. , Pan , J. , Usuda , N. , Yeldandi , A. V. , Rao , M. S. , and Reddy , J. K. ( 1998 ). Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism . J Biol Chem 273 , 15639-15645 .
64. Fischer , J. G. , Glauert , H. P. , Yin , T. , Sweeney-Reeves , M. L. , Larmonier , N. , and Black , M. C. ( 2002 ). Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14,643 . J Nutr 132 , 2525-2531 .
65. Flavell , D. M. , Pineda Torra , I. , Jamshidi , Y. , Evans , D. , Diamond , J. R. , Elkeles , R. S. , Bujac , S. R. , Miller , G. , Talmud , P. J. , Staels , B. , and Humphries , S. E. ( 2000 ). Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects . Diabetologia 43 , 673-680 .
66. Gariot , P. , Barrat , E. , Drouin , P. , Genton , P. , Pointel , J. P. , Foliguet , B. , Kolopp , M. , and Debry , G. ( 1987 ). Morphometric study of human hepatic cell modifications induced by fenofi brate . Metabolism 36 , 203-210 .
67. Gariot , P. , Barrat , E. , Mejean , L. , Pointel , J. P. , Drouin , P. , and Debry , G. ( 1983 ). Fenofi brate and human liver. Lack of proliferation of peroxisomes . Arch Toxicol 53 , 151-163 .
68. Gervois , P. , Torra , I. P. , Chinetti , G. , Grotzinger , T. , Dubois , G. , Fruchart , J. C. , Fruchart-Najib , J. , Leitersdorf , E. , and Staels , B. ( 1999 ). A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity . Mol Endocrinol 13 , 1535-1549 .
69. Gill , J. H. , James , N. H. , Roberts , R. A. , and Dive , C. ( 1998 ). The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas . Carcinogenesis 19 , 299-304 .
70. Glauert , H. P. , Beaty , M. M. , Clark , T. D. , Greenwell , W. S. , Tatum , V. , Chen , L. C. , Borges , T. , Clark , T. L. , Srinivasan , S. R. , and Chow , C. K. ( 1990 ). Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofi brate . J Cancer Res Clin Oncol 116 , 351-356 .
71. Glauert , H. P. , Eyigor , A. , Tharappel , J. C. , Cooper , S. , Lee , E. Y. , and Spear , B. T. ( 2006 ). Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643 . Toxicol Sci 90 , 331-336 .
72. Gloire , G. , Legrand-Poels , S. , and Piette , J. ( 2006 ). NF-kappaB activation by reactive oxygen species: fi fteen years later . Biochem Pharmacol 72 , 1493-1505 .
73. Goel , S. K. , Lalwani , N. D. , and Reddy , J. K. ( 1986 ). Peroxisome proliferation and lipid peroxidation in rat liver . Cancer Res 46 , 1324-1330 .
74. Goll , V. , Alexandre , E. , Viollon-Abadie , C. , Nicod , L. , Jaeck , D. , and Richert , L. ( 1999 ). Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures . Toxicol Appl Pharmacol 160 , 21-32 .
75. Gonzalez , F. J. , and Shah , Y. M. ( 2008 ). PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators . Toxicology 246 , 2-8 .
76. Gottlicher , M. , Widmark , E. , Li , Q. , and Gustafsson , J. A. ( 1992 ). Fatty acids activate a chimera of the clofi bric acid-activated receptor and the glucocorticoid receptor . Proc Natl Acad Sci USA 89 , 4653-4657 .
77. Grasl-Kraupp , B. , Huber , W. , Timmermann-Trosiener , I. , and Schulte-Hermann , R. ( 1993 ). Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin . Carcinogenesis 14 , 2435-2437 .
78. Grasl-Kraupp , B. , Ruttkay-Nedecky , B. , Mullauer , L. , Taper , H. , Huber , W. , Bursch , W. , and Schulte-Hermann , R. ( 1997 ). Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression . Hepatology 25 , 906-912 .
79. Hanefeld , M. , Kemmer , C. , and Kadner , E. ( 1983 ). Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man . Atherosclerosis 46 , 239-246 .
80. Hanefeld , M. , Kemmer , C. , Leonhardt , W. , Kunze , K. D. , Jaross , W. , and Haller , H. ( 1980 ). Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liver . Atherosclerosis 36 , 159-172 .
81. Hanselman , J. C. , Vartanian , M. A. , Koester , B. P. , Gray , S. A. , Essenburg , A. D. , Rea , T. J. , Bisgaier , C. L. , and Pape , M. E. ( 2001 ). Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators . Mol Cell Biochem 217 , 91-97 .
82. Hashimoto , T. ( 1996 ). Peroxisomal beta-oxidation: enzymology and molecular biology . Ann N Y Acad Sci 804 , 86-98 .
83. Hashimoto , T. , Fujita , T. , Usuda , N. , Cook , W. , Qi , C. , Peters , J. M. , Gonzalez , F. J. , Yeldandi , A. V. , Rao , M. S. , and Reddy , J. K. ( 1999 ). Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype . J Biol Chem 274 , 19228-19236 .
84. Hasmall , S. C. , James , N. H. , Macdonald , N. , Gonzalez , F. J. , Peters , J. M. , and Roberts , R. A. ( 2000a ). Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha . Mutat Res 448 , 193-200 .
85. Hasmall , S. C. , James , N. H. , Macdonald , N. , Soames , A. R. , and Roberts , R. A. ( 2000b ). Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression . Arch Toxicol 74 , 85-91 .
86. Hasmall , S. C. , James , N. H. , Macdonald , N. , West , D. , Chevalier , S. , Cosulich , S. C. , and Roberts , R. A. ( 1999 ). Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison of rat and human hepatocytes in vitro . Arch Toxicol 73 , 451-456 .
87. Hasmall , S. C. , James , N. H. , Soames , A. R. , and Roberts , R. A. ( 1998 ). The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro . Arch Toxicol 72 , 777-783 .
88. Hays , T. , Rusyn , I. , Burns , A. M. , Kennett , M. J. , Ward , J. M. , Gonzalez , F. J. , and Peters , J. M. ( 2005 ). Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafi brate-induced hepatocarcinogenesis and cholestasis . Carcinogenesis 26 , 219-227 .
89. Hertz , R. , Bishara-Shieban , J. , and Bar-Tana , J. ( 1995 ). Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III . J Biol Chem 270 , 13470-13475 .
90. Hess , R. , Staubli , W. , and Riess , W. ( 1965 ). Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat . Nature 208 , 856-858 .
91. Hinton , R. H. , Mitchell , F. E. , Mann , A. , Chescoe , D. , Price , S. C. , Nunn , A. , Grasso , P. , and Bridges , J. W. ( 1986 ). Effects of phthalic acid esters on the liver and thyroid . Environ Health Perspect 70 , 195-210 .
92. Hoivik , D. J. , Qualls , C. W. , Jr. , Mirabile , R. C. , Cariello , N. F. , Kimbrough , C. L. , Colton , H. M. , Anderson , S. P. , Santostefano , M. J. , Morgan , R. J. , Dahl , R. R. , Brown , A. R. , Zhao , Z. , Mudd , P. N. , Jr. , Oliver , W. B. , Jr. , Brown , H. R. , and Miller , R. T. ( 2004 ). Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys . Carcinogenesis 25 , 1757-1769 .
93. Holden , P. R. , Hasmall , S. C. , James , N. H. , West , D. R. , Brindle , R. D. , Gonzalez , F. J. , Peters , J. M. , and Roberts , R. A. ( 2000 ). Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin . Cell Mol Biol (Noisy-le-grand) 46 , 29-39 .
94. Holsapple , M. P. , Pitot , H. C. , Cohen , S. M. , Boobis , A. R. , Klaunig , J. E. , Pastoor , T. , Dellarco , V. L. , and Dragan , Y. P. ( 2006 ). Mode of action in relevance of rodent liver tumors to human cancer risk . Toxicol Sci 89 , 51-56 .
95. Hsieh , L. L. , Shinozuka , H. , and Weinstein , I. B. ( 1991 ). Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator . Br J Cancer 64 , 815-820 .
96. Hsu , M. H. , Savas , U. , Griffi n , K. J. , and Johnson , E. F. ( 2001 ). Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells . J Biol Chem 276 , 27950-27958 .
97. Huber , W. , Kraupp-Grasl , B. , Esterbauer , H. , and Schulte-Hermann , R. ( 1991 ). Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat . Cancer Res 51 , 1789-1792 .
98. Huber , W. W. , Grasl-Kraupp , B. , Stekel , H. , Gschwentner , C. , Lang , H. , and Schulte-Hermann , R. ( 1997 ). Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil . Arch Toxicol 71 , 575-581 .
99. Isenberg , J. S. , Kamendulis , L. M. , Ackley , D. C. , Smith , J. H. , Pugh , G. , Jr. , Lington , A. W. , McKee , R. H. , and Klaunig , J. E. ( 2001 ). Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)-and phenobarbital-induced hepatocellular changes in rodents . Toxicol Sci 64 , 192-199 .
100. Isenberg , J. S. , Kamendulis , L. M. , Smith , J. H. , Ackley , D. C. , Pugh , G. , Jr. , Lington , A. W. , and Klaunig , J. E. ( 2000 ). Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver . Toxicol Sci 56 , 73-85 .
101. Isenberg , J. S. , Kolaja , K. L. , Ayoubi , S. A. , Watkins , J. B. , 3rd , and Klaunig , J. E. ( 1997 ). Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone . Carcinogenesis 18 , 1511-1519 .
102. Issemann , I. , and Green , S. ( 1990 ). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators . Nature 347 , 645-650 .
103. Ito , Y. , Yamanoshita , O. , Asaeda , N. , Tagawa , Y. , Lee , C. H. , Aoyama , T. , Ichihara , G. , Furuhashi , K. , Kamijima , M. , Gonzalez , F. J. , and Nakajima , T. ( 2007 ). Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway . J Occup Health 49 , 172-182 .
104. James , N. H. , Gill , J. H. , Brindle , R. , Woodyatt , N. J. , Macdonald , N. , Rolfe , M. , Hasmall , S. C. , Tugwood , J. D. , Holden , P. R. , and Roberts , R. A. ( 1998a ). Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis . Toxicol Lett 102-103 , 91-96 .
105. James , N. H. , and Roberts , R. A. ( 1996 ). Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis . Carcinogenesis 17 , 1623-1632 .
106. James , N. H. , Soames , A. R. , and Roberts , R. A. ( 1998b ). Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB) . Arch Toxicol 72 , 784-790 .
107. Jia , Y. , Qi , C. , Zhang , Z. , Hashimoto , T. , Rao , M. S. , Huyghe , S. , Suzuki , Y. , Van Veldhoven , P. P. , Baes , M. , and Reddy , J. K. ( 2003 ). Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L-and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system . J Biol Chem 278 , 47232-47239 .
108. Karin , M. ( 2006 ). Nuclear factor-kappaB in cancer development and progression . Nature 441 , 431-436 .
109. Kasai , H. ( 1997 ). Analysis of a form of oxidative DNA damage, 8-hydroxy-2 '-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis . Mutat Res 387 , 147-163 .
110. Keller , H. , Devchand , P. R. , Perroud , M. , and Wahli , W. ( 1997 ). PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents . Biol Chem 378 , 651-655 .
111. Keller , H. , Dreyer , C. , Medin , J. , Mahfoudi , A. , Ozato , K. , and Wahli , W. ( 1993 ). Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers . Proc Natl Acad Sci USA 90 , 2160-2164 .
112. Klaunig , J. E. , Babich , M. A. , Baetcke , K. P. , Cook , J. C. , Corton , J. C. , David , R. M. , DeLuca , J. G. , Lai , D. Y. , McKee , R. H. , Peters , J. M. , Roberts , R. A. , and Fenner-Crisp , P. A. ( 2003 ). PPARalpha agonist-induced rodent tumors: modes of action and human relevance . Crit Rev Toxicol 33 , 655-780 .
113. Klaunig , J. E. , Xu , Y. , Isenberg , J. S. , Bachowski , S. , Kolaja , K. L. , Jiang , J. , Stevenson , D. E. , and Walborg , E. F. , Jr. ( 1998 ). The role of oxidative stress in chemical carcinogenesis . Environ Health Perspect 106 (Suppl 1 ), 289-295 .
114. Klungland , A. , Rosewell , I. , Hollenbach , S. , Larsen , E. , Daly , G. , Epe , B. , Seeberg , E. , Lindahl , T. , and Barnes , D. E. ( 1999 ). Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage . Proc Natl Acad Sci USA 96 , 13300-13305 .
115. Lacquemant , C. , Lepretre , F. , Pineda Torra , I. , Manraj , M. , Charpentier , G. , Ruiz , J. , Staels , B. , and Froguel , P. ( 2000 ). Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease . Diabetes Metab 26 , 393-401 .
116. Lake , B. G. , Evans , J. G. , Cunninghame , M. E. , and Price , R. J. ( 1993 ). Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster . Environ Health Perspect 101 ( Suppl 5 ), 241-247 .
117. Lake , B. G. , Evans , J. G. , Gray , T. J. , Korosi , S. A. , and North , C. J. ( 1989a ). Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset . Toxicol Appl Pharmacol 99 , 148-160 .
118. Lake , B. G. , Gray , T. J. , Korosi , S. A. , and Walters , D. G. ( 1989b ). Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats . Toxicol Lett 45 , 221-229 .
119. Lake , B. G. , Kozlen , S. L. , Evans , J. G. , Gray , T. J. , Young , P. J. , and Gangolli , S. D. ( 1987 ). Effect of prolonged administration of clofi bric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat . Toxicology 44 , 213-228 .
120. Lake , B. G. , Rumsby , P. C. , Price , R. J. , and Cunninghame , M. E. ( 2000 ). Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig . Mutat Res 448 , 213-225 .
121. Laughter , A. R. , Dunn , C. S. , Swanson , C. L. , Howroyd , P. , Cattley , R. C. , and Corton , J. C. ( 2004 ). Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver . Toxicology 203 , 83-98 .
122. Lawrence , J. W. , Li , Y. , Chen , S. , DeLuca , J. G. , Berger , J. P. , Umbenhauer , D. R. , Moller , D. E. , and Zhou , G. ( 2001a ). Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson . J Biol Chem 276 , 31521-31527 .
123. Lawrence , J. W. , Wollenberg , G. K. , and DeLuca , J. G. ( 2001b ). Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation . Carcinogenesis 22 , 381-386 .
124. Lawrence , J. W. , Wollenberg , G. K. , Frank , J. D. , and DeLuca , J. G. ( 2001c ). Dexamethasone selectively inhibits WY14,643-induced cell proliferation and not peroxisome proliferation in mice . Toxicol Appl Pharmacol 170 , 113-123 .
125. Li , Y. , Glauert , H. P. , and Spear , B. T. ( 2000a ). Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofi brate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E . Biochem Pharmacol 59 , 427-434 .
126. Li , Y. , Kovach , A. , Suino-Powell , K. , Martynowski , D. , and Xu , H. E. ( 2008 ). Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha . J Biol Chem 283 , 19132-19139 .
127. Li , Y. , Leung , L. K. , Glauert , H. P. , and Spear , B. T. ( 1996 ). Treatment of rats with the peroxisome proliferator ciprofi brate results in increased liver NF-kappaB activity . Carcinogenesis 17 , 2305-2309 .
128. Li , Y. , Tharappel , J. C. , Cooper , S. , Glenn , M. , Glauert , H. P. , and Spear , B. T. ( 2000b ). Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB . DNA Cell Biol 19 , 113-120 .
129. Liu , M. H. , Li , J. , Shen , P. , Husna , B. , Tai , E. S. , and Yong , E. L. ( 2008 ). A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin . Mol Endocrinol 22 , 1078-1092 .
130. Luebker , D. J. , Hansen , K. J. , Bass , N. M. , Butenhoff , J. L. , and Seacat , A. M. ( 2002 ). Interactions of fl uorochemicals with rat liver fatty acid-binding protein . Toxicology 176 , 175-185 .
131. MacDonald , N. , Holden , P. R. , and Roberts , R. A. ( 1999 ). Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators . Cancer Res 59 , 4776-4780 .
132. Maeda , S. , Kamata , H. , Luo , J. L. , Leffert , H. , and Karin , M. ( 2005 ). IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis . Cell 121 , 977-990 .
133. Makowska , J. M. , Gibson , G. G. , and Bonner , F. W. ( 1992 ). Species differences in ciprofi brate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation . J Biochem Toxicol 7 , 183-191 .
134. Maloney , E. K. , and Waxman , D. J. ( 1999 ). trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals . Toxicol Appl Pharmacol 161 , 209-218 .
135. Mannaerts , G. P. , and van Veldhoven , P. P. ( 1996 ). Functions and organization of peroxisomal beta-oxidation . Ann NY Acad Sci 804 , 99-115 .
136. Marsman , D. S. , Cattley , R. C. , Conway , J. G. , and Popp , J. A. ( 1988 ). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats . Cancer Res 48 , 6739-6744 .
137. Marsman , D. S. , Goldsworthy , T. L. , and Popp , J. A. ( 1992 ). Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofi bric acid . Carcinogenesis 13 , 1011-1017 .
138. Marsman , D. S. , and Popp , J. A. ( 1994 ). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643 . Carcinogenesis 15 , 111-117 .
139. Mascaro , C. , Acosta , E. , Ortiz , J. A. , Marrero , P. F. , Hegardt , F. G. , and Haro , D. ( 1998 ). Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor . J Biol Chem 273 , 8560-8563 .
140. Meek , M. E. ( 2008 ). Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals . Environ Mol Mutagen 49 , 110-116 .
141. Menegazzi , M. , Carcereri-De Prati , A. , Suzuki , H. , Shinozuka , H. , Pibiri , M. , Piga , R. , Columbano , A. , and Ledda-Columbano , G. M. ( 1997 ). Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha . Hepatology 25 , 585-592 .
142. Meyer , K. , Lee , J. S. , Dyck , P. A. , Cao , W. Q. , Rao , M. S. , Thorgeirsson , S. S. , and Reddy , J. K. ( 2003 ). Molecular profi ling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase defi-cient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen . Carcinogenesis 24 , 975-984 .
143. Morimura , K. , Cheung , C. , Ward , J. M. , Reddy , J. K. , and Gonzalez , F. J. ( 2006 ). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis . C arcinogenesis 27 , 1074-1080 .
144. Mukherjee , R. , Jow , L. , Noonan , D. , and McDonnell , D. P. ( 1994 ). Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators . J Steroid Biochem Mol Biol 51 , 157-166 .
145. Nemali , M. R. , Usuda , N. , Reddy , M. K. , Oyasu , K. , Hashimoto , T. , Osumi , T. , Rao , M. S. , and Reddy , J. K. ( 1988 ). Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat . Cancer Res 48 , 5316-5324 .
146. Nicholls-Grzemski , F. A. , Belling , G. B. , Priestly , B. G. , Calder , I. C. , and Burcham , P. C. ( 2000 ). Clofi brate pretreatment in mice confers resistance against hepatic lipid peroxidation . J Biochem Mol Toxicol 14 , 335-345 .
147. Nilakantan , V. , Spear , B. T. , and Glauert , H. P. ( 1998 ). Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofi brate . Carcinogenesis 19 , 631-637 .
148. O'Brien , M. L. , Cunningham , M. L. , Spear , B. T. , and Glauert , H. P. ( 2001a ). Effects of peroxisome proliferators on glutathione and glutathione-related enzymes in rats and hamsters . Toxicol Appl Pharmacol 171 , 27-37 .
149. O'Brien , M. L. , Twaroski , T. P. , Cunningham , M. L. , Glauert , H. P. , and Spear , B. T. ( 2001b ). Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters . Toxicol Sci 60 , 271-278 .
150. Oberhammer , F. A. , and Qin , H. M. ( 1995 ). Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1 . Carcinogenesis 16 , 1363-1371 .
151. Ohmura , T. , Ledda-Columbano , G. M. , Piga , R. , Columbano , A. , Glemba , J. , Katyal , S. L. , Locker , J. , and Shinozuka , H. ( 1996 ). Hepatocyte proliferation induced by a single dose of a peroxisome proliferator . Am J Pathol 148 , 815-824 .
152. Pacot , C. , Petit , M. , Rollin , M. , Behechti , N. , Moisant , M. , Deslex , P. , Althoff , J. , Lhuguenot , J. C. , and Latruffe , N. ( 1996 ). Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofi brate . Arch Biochem Biophys 327 , 181-188 .
153. Palmer , C. N. , Hsu , M. H. , Griffi n , K. J. , Raucy , J. L. , and Johnson , E. F. ( 1998 ). Peroxisome proliferator activated receptor-alpha expression in human liver . Mol Pharmacol 53 , 14-22 .
154. Perrone , C. E. , Shao , L. , and Williams , G. M. ( 1998 ). Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes . Toxicol Appl Pharmacol 150 , 277-286 .
155. Peters , J. M. , Aoyama , T. , Cattley , R. C. , Nobumitsu , U. , Hashimoto , T. , and Gonzalez , F. J. ( 1998 ). Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver . Carcinogenesis 19 , 1989-1994 .
156. Peters , J. M. , Cattley , R. C. , and Gonzalez , F. J. ( 1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 . Carcinogenesis 18 , 2029-2033 .
157. Peters , J. M. , Cheung , C. , and Gonzalez , F. J. ( 2005 ). Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? J Mol Med 83 , 774-785 .
158. Peters , J. M. , Rusyn , I. , Rose , M. L. , Gonzalez , F. J. , and Thurman , R. G. ( 2000 ). Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis . Carcinogenesis 21 , 823-826 .
159. Plant , N. J. , Horley , N. J. , Dickins , M. , Hasmall , S. , Elcombe , C. R. , and Bell , D. R. ( 1998 ). The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate . Carcinogenesis 19 , 1521-1527 .
160. Price , R. J. , Evans , J. G. , and Lake , B. G. ( 1992 ). Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster . Food Chem Toxicol 30 , 937-944 .
161. Pugh , G. , Jr. , Isenberg , J. S. , Kamendulis , L. M. , Ackley , D. C. , Clare , L. J. , Brown , R. , Lington , A. W. , Smith , J. H. , and Klaunig , J. E. ( 2000 ). Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofi brate in cynomolgus monkeys . Toxicol Sci 56 , 181-188 .
162. Qu , B. , Halliwell , B. , Ong , C. N. , Lee , B. L. , and Li , Q. T. ( 2000 ). Caloric restriction prevents oxidative damage induced by the carcinogen clofi brate in mouse liver . FEBS Lett 473 , 85-88 .
163. Qu , B. , Li , Q. T. , Wong , K. P. , Tan , T. M. , and Halliwell , B. ( 2001 ). Mechanism of clofi brate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes . Free Radic Biol Med 31 , 659-669 .
164. Rao , M. S. , Lalwani , N. D. , Scarpelli , D. G. , and Reddy , J. K. ( 1982 ). The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643 . Carcinogenesis 3 , 1231-1233 .
165. Rao , M. S. , Lalwani , N. D. , Watanabe , T. K. , and Reddy , J. K. ( 1984 ). Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofi brate, a peroxisome proliferator . Cancer Res 44 , 1072-1076 .
166. Rao , M. S. , and Subbarao , V. ( 1997a ). The effect of deferoxamine on ciprofi brate-induced hepatocarcinogenesis in the rat . In Vivo 11 , 495-498 .
167. Rao , M. S. , and Subbarao , V. ( 1997b ). Effect of dexamethasone on ciprofi brate-induced cell proliferation and peroxisome proliferation . Fundam Appl Toxicol 35 , 78-83 .
168. Rao , M. S. , and Subbarao , V. ( 1999 ). Inhibition of ciprofi brate-induced hepatocarcinogenesis in the rat by dimethylthiourea, a scavenger of hydroxyl radical . Oncol Rep 6 , 1285-1288 .
169. Rao , M. S. , Tatematsu , M. , Subbarao , V. , Ito , N. , and Reddy , J. K. ( 1986 ). Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase . Cancer Res 46 , 5287-5290 .
170. Rao , M. S. , Thangada , S. , and Subbarao , V. ( 1991 ). Peroxisome proliferation in neoplastic nodules and hepatocellular carcinomas induced by ciprofi brate in the rat . Exp Pathol 41 , 44-49 .
171. Rao , M. S. , Usuda , N. , Subbarao , V. , and Reddy , J. K. ( 1987 ). Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator . Carcinogenesis 8 , 1347-1350 .
172. Ray , A. , and Prefontaine , K. E. ( 1994 ). Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor . Proc Natl Acad Sci USA 91 , 752-756 .
173. Reddy , J. K. , and Chu , R. ( 1996 ). Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon . A nn NY Acad Sci 804 , 176-201 .
174. Reddy , J. K. , Lalwani , N. D. , Reddy , M. K. , and Qureshi , S. A. ( 1982 ). Excessive accumulation of autofl uorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators . Cancer Res 42 , 259-266 .
175. Reddy , J. K. , and Qureshi , S. A. ( 1979 ). Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofi brate) in rats . Br J Cancer 40 , 476-482 .
176. Reddy , J. K. , and Rao , M. S. ( 1977 ). Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator . J Natl Cancer Inst 59 , 1645-1650 .
177. Reddy , J. K. , and Rao , M. S. ( 1989 ). Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis . Mutat Res 214 , 63-68 .
178. Ren , H. , Aleksunes , L. M. , Wood , C. , Vallanat , B. , George , M. H. , Klaassen , C. D. , and Corton , J. C. ( 2010 ). Characterization of peroxisome proliferator-activated receptor alpha-independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor . Toxicol Sci 113 ( 1 ), 45-59 .
179. Richert , L. , Lamboley , C. , Viollon-Abadie , C. , Grass , P. , Hartmann , N. , Laurent , S. , Heyd , B. , Mantion , G. , Chibout , S. D. , and Staedtler , F. ( 2003 ). Effects of clofi bric acid on mRNA expression profi les in primary cultures of rat, mouse and human hepatocytes . Toxicol Appl Pharmacol 191 , 130-146 .
180. Roberts , R. A. ( 1999 ). Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences . Arch Toxicol 73 , 413-418 .
181. Roberts , R. A. , Ganey , P. E. , Ju , C. , Kamendulis , L. M. , Rusyn , I. , and Klaunig , J. E. ( 2007 ). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis . Toxicol Sci 96 , 2-15 .
182. Roberts , R. A. , James , N. H. , Hasmall , S. C. , Holden , P. R. , Lambe , K. , Macdonald , N. , West , D. , Woodyatt , N. J. , and Whitcome , D. ( 2000 ). Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha . Toxicol Lett 112-113 , 49-57 .
183. Roglans , N. , Bellido , A. , Rodriguez , C. , Cabrero , A. , Novell , F. , Ros , E. , Zambon , D. , and Laguna , J. C. ( 2002 ). Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver . Clin Pharmacol Ther 72 , 692-701 .
184. Rolfe , M. , James , N. H. , and Roberts , R. A. ( 1997 ). Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 18 , 2277-2280 .
185. Rose , M L. , Cattley , R. C. , Dunn , C. , Wong , V. , Li , X. , and Thurman , R. G. ( 1999a ). Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643 . Carcinogenesis 20 , 2075-2081 .
186. Rose , M. L. , Germolec , D. , Arteel , G. E. , Schoonhoven , R. , and Thurman , R. G. ( 1997a ). Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643 . Chem Res Toxicol 10 , 1198-1204 .
187. Rose , M. L. , Germolec , D. R. , Schoonhoven , R. , and Thurman , R. G. ( 1997b ). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators . Carcinogenesis 18 , 1453-1456 .
188. Rose , M. L. , Rivera , C. A. , Bradford , B. U. , Graves , L. M. , Cattley , R. C. , Schoonhoven , R. , Swenberg , J. A. , and Thurman , R. G. ( 1999b ). Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators . Carcinogenesis 20 , 27-33 .
189. Rosen , M. B. , Abbott , B. D. , Wolf , D. C. , Corton , J. C. , Wood , C. R. , Schmid , J. E. , Das , K. P. , Zehr , R. D. , Blair , E. T. , and Lau , C. ( 2008a ). Gene profi ling in the livers of wild-type and PPARalpha-null mice exposed to perfl uorooctanoic acid . Toxicol Pathol 36 , 592-607 .
190. Rosen , M. B. , Lee , J. S. , Ren , H. , Vallanat , B. , Liu , J. , Waalkes , M. P. , Abbott , B. D. , Lau , C. , and Corton , J. C. ( 2008b ). Toxicogenomic dissection of the perfl uorooctanoic acid transcript profi le in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR . Toxicol Sci 103 , 46-56 .
191. Rusyn , I. , Asakura , S. , Pachkowski , B. , Bradford , B. U. , Denissenko , M. F. , Peters , J. M. , Holland , S. M. , Reddy , J. K. , Cunningham , M. L. , and Swenberg , J. A. ( 2004 ). Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators . Cancer Res 64 , 1050-1057 .
192. Rusyn , I. , Denissenko , M. F. , Wong , V. A. , Butterworth , B. E. , Cunningham , M. L. , Upton , P. B. , Thurman , R. G. , and Swenberg , J. A. ( 2000a ). Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency . Carcinogenesis 21 , 2141-2145 .
193. Rusyn , I. , Kadiiska , M. B. , Dikalova , A. , Kono , H. , Yin , M. , Tsuchiya , K. , Mason , R. P. , Peters , J. M. , Gonzalez , F. J. , Segal , B. H. , Holland , S. M. , and Thurman , R. G. ( 2001 ). Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells . Mol Pharmacol 59 , 744-750 .
194. Rusyn , I. , Peters , J. M. , and Cunningham , M. L. ( 2006 ). Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver . Crit Rev Toxicol 36 , 459-479 .
195. Rusyn , I. , Rose , M. L. , Bojes , H. K. , and Thurman , R. G. ( 2000b ). Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators . Antioxid Redox Signal 2 , 607-621 .
196. Rusyn , I. , Tsukamoto , H. , and Thurman , R. G. ( 1998 ). WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes . Carcinogenesis 19 , 1217-1222 .
197. Rusyn , I. , Yamashina , S. , Segal , B. H. , Schoonhoven , R. , Holland , S. M. , Cattley , R. C. , Swenberg , J. A. , and Thurman , R. G. ( 2000c ). Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators . Cancer Res 60 , 4798-4803 .
198. Sanderson , L. M. , de Groot , P. J. , Hooiveld , G. J. , Koppen , A. , Kalkhoven , E. , Muller , M. , and Kersten , S. ( 2008 ). Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics . PLoS ONE 3 , e 1681 .
199. Sapone , A. , Peters , J. M. , Sakai , S. , Tomita , S. , Papiha , S. S. , Dai , R. , Friedman , F. K. , and Gonzalez , F. J. ( 2000 ). The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants . Pharmacogenetics 10 , 321-333 .
200. Sausen , P. J. , Lee , D. C. , Rose , M. L. , and Cattley , R. C. ( 1995 ). Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations . Carcinogenesis 16 , 1795-1801 .
201. Schmezer , P. , Pool , B. L. , Klein , R. G. , Komitowski , D. , and Schmahl , D. ( 1988 ). Various short-term assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate in the Syrian golden hamster . Carcinogenesis 9 , 37-43 .
202. Schoonjans , K. , Peinado-Onsurbe , J. , Lefebvre , A. M. , Heyman , R. A. , Briggs , M. , Deeb , S. , Staels , B. , and Auwerx , J. ( 1996 ). PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene . EMBO J 15 , 5336-5348 .
203. Schulte-Hermann , R. , Ohde , G. , Schuppler , J. , and Timmermann-Trosiener , I. ( 1981 ). Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin . Cancer Res 41 , 2556-2562 .
204. Seo , K. W. , Kim , K. B. , Kim , Y. J. , Choi , J. Y. , Lee , K. T. , and Choi , K. S. ( 2004 ). Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats . Food Chem Toxicol 42 , 107-114 .
205. Shah , Y. M. , Morimura , K. , Yang , Q. , Tanabe , T. , Takagi , M. , and Gonzalez , F. J. ( 2007 ). Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation . Mol Cell Biol 27 , 4238-4247 .
206. Shaw , D. , Lee , R. , and Roberts , R. A. ( 2002 ). Species differences in response to the phthalate plasticizer monoisononylphthalate (MINP) in vitro: a comparison of rat and human hepatocytes . Arch Toxicol 76 , 344-350 .
207. Sher , T. , Yi , H. F. , McBride , O. W. , and Gonzalez , F. J. ( 1993 ). cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor . Biochemistry 32 , 5598-5604 .
208. Shipley , J. M. , Hurst , C. H. , Tanaka , S. S. , DeRoos , F. L. , Butenhoff , J. L. , Seacat , A. M. , and Waxman , D. J. ( 2004 ). trans-activation of PPARalpha and induction of PPARalpha target genes by perfl uorooctane-based chemicals . Toxicol Sci 80 , 151-160 .
209. Smith-Oliver , T. , and Butterworth , B. E. ( 1987 ). Correlation of the carcinogenic potential of di(2-ethylhexyl) phthalate (DEHP) with induced hyperplasia rather than with genotoxic activity . Mutat Res 188 , 21-28 .
210. Soames , A. R. , Cliffe , S. , Pate , I. , and Foster , J. R. ( 1999 ). Quantitative analysis of the lobular distribution of S-phase in rat liver following dietary administration of di(2-ethylhexyl)phthalate . Toxicol Pathol 27 , 436-440 .
211. Soliman , M. S. , Cunningham , M. L. , Morrow , J. D. , Roberts , L. J. , 2nd , and Badr , M. Z. ( 1997 ). Evidence against peroxisome proliferation-induced hepatic oxidative damage . Biochem Pharmacol 53 , 1369-1374 .
212. Staels , B. , Schoonjans , K. , Fruchart , J. C. , and Auwerx , J. ( 1997 ). The effects of fi brates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs) . Biochimie 79 , 95-99 .
213. Stanko , R. T. , Sekas , G. , Isaacson , I. A. , Clarke , M. R. , Billiar , T. R. , and Paul , H. S. ( 1995 ). Pyruvate inhibits clofi brate-induced hepatic peroxisomal proliferation and free radical production in rats . Metabolism 44 , 166-171 .
214. Styles , J. A. , Kelly , M. , Pritchard , N. R. , and Elcombe , C. R. ( 1988 ). A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte . Carcinogenesis 9 , 1647-1655 .
215. Styles , J. A. , Kelly , M. D. , Pritchard , N. R. , and Elcombe , C. R. ( 1990 ). Acute hyperplasia and peroxisome proliferation induced by methylclofenapate: a species comparison and implications for liver carcinogenesis . Prog Clin Biol Res 331 , 385-393 .
216. Svoboda , D. J. , and Azarnoff , D. L. ( 1979 ). Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug . Cancer Res 39 , 3419-3428 .
217. Tachibana , K. , Kobayashi , Y. , Tanaka , T. , Tagami , M. , Sugiyama , A. , Katayama , T. , Ueda , C. , Yamasaki , D. , Ishimoto , K. , Sumitomo , M. , Uchiyama , Y. , Kohro , T. , Sakai , J. , Hamakubo , T. , Kodama , T. , and Doi , T. ( 2005 ). Gene expression profi ling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms . Nucl Recept 3 , 3 .
218. Tai , E. S. , Demissie , S. , Cupples , L. A. , Corella , D. , Wilson , P. W. , Schaefer , E. J. , and Ordovas , J. M. ( 2002 ). Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study . Arterioscler Thromb Vasc Biol 22 , 805-810 .
219. Takacs , M. L. , and Abbott , B. D. ( 2007 ). Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfl uorooctanoic acid and perfl uorooctane sulfonate . Toxicol Sci 95 , 108-117 .
220. Takagi , A. , Sai , K. , Umemura , T. , Hasegawa , R. , and Kurokawa , Y. ( 1990 ). Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate . Jpn J Cancer Res 81 , 213-215 .
221. Takashima , K. , Ito , Y. , Gonzalez , F. J. , and Nakajima , T. ( 2008 ). Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type and Ppar alpha-null mice . J Occup Health 50 , 169-180 .
222. Tanaka , K. , Smith , P. F. , Stromberg , P. C. , Eydelloth , R. S. , Herold , E. G. , Grossman , S. J. , Frank , J. D. , Hertzog , P. R. , Soper , K. A. , and Keenan , K. P. ( 1992 ). Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofi brate . Toxicol Appl Pharmacol 116 , 71-77 .
223. Tanaka , N. , Moriya , K. , Kiyosawa , K. , Koike , K. , and Aoyama , T. ( 2008a ). Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis . Int J Cancer 122 , 124-131 .
224. Tanaka , N. , Moriya , K. , Kiyosawa , K. , Koike , K. , Gonzalez , F. J. , and Aoyama , T. ( 2008b ). PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice . J Clin Invest 118 , 683-694 .
225. Tharappel , J. C. , Cunningham , M. L. , Spear , B. T. , and Glauert , H. P. ( 2001 ). Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfi brozil, and dibutyl phthalate . Toxicol Sci 62 , 20-27 .
226. Tharappel , J. C. , Nalca , A. , Owens , A. B. , Ghabrial , L. , Konz , E. C. , Glauert , H. P. , and Spear , B. T. ( 2003 ). Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofi brate . Toxicol Sci 75 , 300-308 .
227. Thottassery , J. , Winberg , L. , Youssef , J. , Cunningham , M. , and Badr , M. ( 1992 ). Regulation of perfl uorooctanoic acid-induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones . Hepatology 15 , 316-322 .
228. Tomaszewski , K. E. , Heindel , S. W. , Jenkins , W. L. , and Melnick , R. L. ( 1990 ). Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures . Toxicology 65 , 49-60 .
229. Trapp , C. , Schwarz , M. , and Epe , B. ( 2007 ). The peroxisome proliferator WY-14,643 promotes hepatocarcinogenesis caused by endogenously generated oxidative DNA base modifications in repair-deficient Csbm/m/Ogg1-/-mice . Cancer Res 67 , 5156-5161 .
230. Tugwood , J. D. , Aldridge , T. C. , Lambe , K. G. , Macdonald , N. , and Woodyatt , N. J. ( 1996 ). Peroxisome proliferator-activated receptors: structures and function . Ann NY Acad Sci 804 , 252-265 .
231. Tugwood , J. D. , Holden , P. R. , James , N. H. , Prince , R. A. , and Roberts , R. A. ( 1998 ). A peroxisome proliferator-activated receptor-alpha (PPARalpha) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARalpha: implications for species differences in responses to peroxisome proliferators . Arch Toxicol 72 , 169-177 .
232. Valles , E. G. , Laughter , A. R. , Dunn , C. S. , Cannelle , S. , Swanson , C. L. , Cattley , R. C. , and Corton , J. C. ( 2003 ). Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate . Toxicology 191 , 211-225 .
233. Van Rafelghem , M. J. , Mattie , D. R. , Bruner , R. H. , and Andersen , M. E. ( 1987 ). Pathological and hepatic ultrastructural effects of a single dose of perfl uoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig . Fundam Appl Toxicol 9 , 522-540 .
234. Vanden Heuvel , J. P. , Thompson , J. T. , Frame , S. R. , and Gillies , P. J. ( 2006 ). Differential activation of nuclear receptors by perfl uorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha,-beta, and-gamma, liver X receptor-beta, and retinoid X receptor-alpha . Toxicol Sci 92 , 476-489 .
235. Varanasi , U. , Chu , R. , Huang , Q. , Castellon , R. , Yeldandi , A. V. , and Reddy , J. K. ( 1996 ). Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene . J Biol Chem 271 , 2147-2155 .
236. Vu-Dac , N. , Schoonjans , K. , Kosykh , V. , Dallongeville , J. , Fruchart , J. C. , Staels , B. , and Auwerx , J. ( 1995 ). Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor . J Clin Invest 96 , 741-750 .
237. Vu-Dac , N. , Schoonjans , K. , Laine , B. , Fruchart , J. C. , Auwerx , J. , and Staels , B. ( 1994 ). Negative regulation of the human apolipoprotein A-I promoter by fi brates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element . J Biol Chem 269 , 31012-31018 .
238. Wada , N. , Marsman , D. S. , and Popp , J. A. ( 1992 ). Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication . Fundam Appl Toxicol 18 , 149-154 .
239. Wahli , W. , Braissant , O. , and Desvergne , B. ( 1995 ). Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more . Chem Biol 2 , 261-266 .
240. Watanabe , T. , Horie , S. , Yamada , J. , Isaji , M. , Nishigaki , T. , Naito , J. , and Suga , T. ( 1989 ). Species differences in the effects of bezafi brate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes . Biochem Pharmacol 38 , 367-371 .
241. West , D. A. , James , N. H. , Cosulich , S. C. , Holden , P. R. , Brindle , R. , Rolfe , M. , and Roberts , R. A. ( 1999 ). Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin . Hepatology 30 , 1417-1424 .
242. Widen , C. , Gustafsson , J. A. , and Wikstrom , A. C. ( 2003 ). Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells . Biochem J 373 , 211-220 .
243. Williams , G. M. , and Perrone , C. ( 1996 ). Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens . Ann NY Acad Sci 804 , 554-572 .
244. Wolf , D. C. , Moore , T. , Abbott , B. D. , Rosen , M. B. , Das , K. P. , Zehr , R. D. , Lindstrom , A. B. , Strynar , M. J. , and Lau , C. ( 2008 ). Comparative hepatic effects of perfl uorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice . Toxicol Pathol 36 , 632-639 .
245. Woods , C. G. , Burns , A. M. , Bradford , B. U. , Ross , P. K. , Kosyk , O. , Swenberg , J. A. , Cunningham , M. L. , and Rusyn , I. ( 2007a ). WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase . Toxicol Sci 98 , 366-374 .
246. Woods , C. G. , Burns , A. M. , Maki , A. , Bradford , B. U. , Cunningham , M. L. , Connor , H. D. , Kadiiska , M. B. , Mason , R. P. , Peters , J. M. , and Rusyn , I. ( 2007b ). Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase . Free Radic Biol Med 42 , 335-342 .
247. Woods , C. G. , Kosyk , O. , Bradford , B. U. , Ross , P. K. , Burns , A. M. , Cunningham , M. L. , Qu , P. , Ibrahim , J. G. , and Rusyn , I. ( 2007c ). Time course investigation of PPARalpha-and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression . Toxicol Appl Pharmacol 225 , 267-277 .
248. Woodyatt , N. J. , Lambe , K. G. , Myers , K. A. , Tugwood , J. D. , and Roberts , R. A. ( 1999 ). The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs . Carcinogenesis 20 , 369-372 .
249. Xiao , S. , Anderson , S. P. , Swanson , C. , Bahnemann , R. , Voss , K. A. , Stauber , A. J. , and Corton , J. C. ( 2006 ). Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver . Toxicol Sci 92 , 368-377 .
250. Xu , H. E. , and Li , Y. ( 2008 ). Ligand-dependent and-independent regulation of PPAR gamma and orphan nuclear receptors . Sci Signal 1 , pe 52 .
251. Yamakawa-Kobayashi , K. , Ishiguro , H. , Arinami , T. , Miyazaki , R. , and Hamaguchi , H. ( 2002 ). A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels . J Med Genet 39 , 189-191 .
252. Yang , Q. , Ito , S. , and Gonzalez , F. J. ( 2007 ). Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis . Carcinogenesis 28 , 1171-1177 .
253. Yang , Q. , Nagano , T. , Shah , Y. , Cheung , C. , Ito , S. , and Gonzalez , F. J. ( 2008 ). The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha . Toxicol Sci 101 , 132-139 .
254. Yeldandi , A. V. , Milano , M. , Subbarao , V. , Reddy , J. K. , and Rao , M. S. ( 1989 ). Evaluation of liver cell proliferation during ciprofi brate-induced hepatocarcinogenesis . Cancer Lett 47 , 21-27 .
255. Yeldandi , A. V. , Rao , M. S. , and Reddy , J. K. ( 2000 ). Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis . Mutat Res 448 , 159-177 .
256. Youssef , J. A. , Bouziane , M. , and Badr , M. Z. ( 2003 ). Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo . Mech Ageing Dev 124 , 333-340 .